Before you enter into the due diligence process with a target partner, you will want to have a detailed reimbursement strategy in place for your product. The feasibility and clarity of this strategy will give your target partner confidence that the financial projections for your product's reimbursement is achievable and that they will realize a return on their investment. TDA can help you prepare for negotiations by analyzing the current market access environment for your product, modeling current payer reimbursement for you target indication, and conducting comparative effectiveness research into the additional benefits of your intervention over the current standard of care. We have access to large data sets that include 100s of millions of patient encounters represented by EHRs and medical claims and which can be used for rigorous, observational pharmaco-economic studies into the efficacy of your product's intervention.